Journey Medical Corporation

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 5.17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 145.92M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to se...